Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

AstraZeneca to Pay $520 Million for Off-label Drug Marketing



AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve whistleblower allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for off-label uses, federal officials announced.
Name:
E-mail:
Website:  
Please enter your comment below:
Please enter the text below: